Our 13 year old son was diagnosed with bipolar disorder at age five. He has struggled through two hospitalizations, 5 schools in 8 years and daily suffering that is indescribable. We tried all conventional medications. In July 2011, we put him under the care of Dr. Papolos who diagnosed him with the fear of harm phenotype, and he entered into the pilot Ketamine research study through JBRF. Not only is he now successfully attending school, but he can accept limits and navigate the ups and downs of daily life. For the first time we feel like he has a future. We are forever grateful for the important and necessary work of the JBRF. The lives of children like ours and their families and communities depend on it.